Cargando…

Current advances in the development of SARS-CoV-2 vaccines

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is now a global pandemic that has wreaked havoc globally, which has put a heavy toll on public health, lives, and the world economy. Vaccination is considered as one of the greatest successes i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Awadasseid, Annoor, Wu, Yanling, Tanaka, Yoshimasa, Zhang, Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757035/ https://www.ncbi.nlm.nih.gov/pubmed/33390829 http://dx.doi.org/10.7150/ijbs.52569

Ejemplares similares

Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines
por: Awadasseid, Annoor, et al.
Publicado: (2021)

SARS-CoV-2 variants evolved during the early stage of the pandemic and effects of mutations on adaptation in Wuhan populations
por: Awadasseid, Annoor, et al.
Publicado: (2021)

Potential protective role of the anti-PD-1 blockade against SARS-CoV-2 infection
por: Awadasseid, Annoor, et al.
Publicado: (2021)

New Advances in Canonical Wnt/β-Catenin Signaling in Cancer
por: Wen, Xiaolan, et al.
Publicado: (2020)

Initial success in the identification and management of the coronavirus disease 2019 (COVID-19) indicates human-to-human transmission in Wuhan, China
por: Awadasseid, Annoor, et al.
Publicado: (2020)

Extracellular Vesicles (Exosomes) as Immunosuppressive Mediating Variables in Tumor and Chronic Inflammatory Microenvironments
por: Awadasseid, Annoor, et al.
Publicado: (2021)

The Variation of SARS-CoV-2 and Advanced Research on Current Vaccines
por: Jiang, Yao, et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Development: Current Status
por: Poland, Gregory A., et al.
Publicado: (2020)

Advances in the design and development of SARS-CoV-2 vaccines
por: Peng, Xue-Liang, et al.
Publicado: (2021)

The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development
por: Alturki, Sana O., et al.
Publicado: (2020)

SARS-CoV-2: characteristics and current advances in research
por: Yang, Yicheng, et al.
Publicado: (2020)

Advanced Materials for SARS‐CoV‐2 Vaccines
por: Mabrouk, Moustafa T., et al.
Publicado: (2022)

Development of vaccines for SARS-CoV-2
por: Ng, Wern Hann, et al.
Publicado: (2020)

SARS-CoV-2 vaccine development
por: Mtewa, Andrew G., et al.
Publicado: (2022)

Fundamental and Advanced Therapies, Vaccine Development against SARS-CoV-2
por: Hudakova, Nikola, et al.
Publicado: (2021)

Current advancements and potential strategies in the development of MERS-CoV vaccines
por: Zhang, Naru, et al.
Publicado: (2014)

The conundrum of current anti-SARS-CoV-2 vaccines
por: Federico, Maurizio
Publicado: (2021)

SARS-CoV-2 virus: Vaccines in development
por: Huang, Qingrui, et al.
Publicado: (2021)

Development of an inactivated vaccine candidate for SARS-CoV-2
por: Gao, Qiang, et al.
Publicado: (2020)

Vaccines and Therapies in Development for SARS-CoV-2 Infections
por: Wu, David, et al.
Publicado: (2020)

Current status of therapeutic approaches and vaccines for SARS-CoV-2
por: Wahid, Braira, et al.
Publicado: (2021)

COVID-19: An Overview of SARS-CoV-2 Variants—The Current Vaccines and Drug Development
por: Bostanghadiri, Narjess, et al.
Publicado: (2023)

Protein-based nano-vaccines against SARS-CoV-2: Current design strategies and advances of candidate vaccines
por: Wang, Dongliang, et al.
Publicado: (2023)

A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines
por: Abdolmaleki, Gelareh, et al.
Publicado: (2022)

Insight into the Advances in Clinical Trials of SARS-CoV-2 Vaccines
por: Basheeruddin Asdaq, Syed Mohammed, et al.
Publicado: (2022)

Evaluation of vaccine effectiveness against SARS‐CoV‐2 variants by serological epitope profiling
por: Li, Cheng, et al.
Publicado: (2023)

Advances in the Development of SARS-CoV-2 Mpro Inhibitors
por: Agost-Beltrán, Laura, et al.
Publicado: (2022)

SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021)

SARS-CoV-2 vaccine development, access, and equity
por: Kim, Jerome H.
Publicado: (2020)

SARS-CoV-2 Vaccine Development: An Overview and Perspectives
por: Liu, Yi, et al.
Publicado: (2020)

Approaches and Challenges in SARS-CoV-2 Vaccine Development
por: Dagotto, Gabriel, et al.
Publicado: (2020)

Timely development of vaccines against SARS-CoV-2
por: Lu, Shan
Publicado: (2020)

Platforms Exploited for SARS-CoV-2 Vaccine Development
por: Mathew, Shilu, et al.
Publicado: (2020)

SARS-CoV-2: Targeted managements and vaccine development
por: Bakhiet, Moiz, et al.
Publicado: (2021)

Development of an Inactivated Vaccine against SARS CoV-2
por: Pavel, Shaikh Terkis Islam, et al.
Publicado: (2021)

HIV and SARS-CoV-2 Pathogenesis and Vaccine Development
por: Fleury, Herve
Publicado: (2022)

Development of SARS-CoV-2 Vaccine: Challenges and Prospects
por: Mahboob, Tooba, et al.
Publicado: (2023)

The development of DNA vaccines against SARS-CoV-2
por: Khalid, Kanwal, et al.
Publicado: (2023)

Current vaccine strategies against SARS-CoV-2: Promises and challenges
por: Kurup, Drishya, et al.
Publicado: (2022)

SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19
por: Liang, Hong-Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_44crdtt5rb9mhb0fh0neorg3ip